Old Web
English
Sign In
Acemap
>
authorDetail
>
Nisebita Sahu
Nisebita Sahu
Genentech
Biology
Cancer
Adenocarcinoma
Metabolite
Immunology
5
Papers
262
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma
2017
Molecular Cancer Therapeutics
Nisebita Sahu
Emily Chan
Felix Chu
Thinh Pham
Hartmut Koeppen
William F. Forrest
Mark Merchant
Jeffrey Settleman
Show All
Source
Cite
Save
Citations (17)
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs
2016
Nature Communications
Nisebita Sahu
Jean-Philippe Stephan
Darlene Dela Cruz
Mark Merchant
Benjamin Haley
Richard Bourgon
Marie Classon
Jeffrey Settleman
Show All
Source
Cite
Save
Citations (18)
Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
2015
Proceedings of the National Academy of Sciences of the United States of America
Anneleen Daemen
David A. Peterson
Nisebita Sahu
Ron McCord
Xiangnan Du
Bonnie Liu
Katarzyna Kowanetz
Rebecca Hong
John Moffat
Min Gao
Aaron Boudreau
Rana Mroue
Laura Corson
Thomas OBrien
Jing Qing
Deepak Sampath
Mark Merchant
Robert L. Yauch
Gerard Manning
Jeffrey Settleman
Georgia Hatzivassiliou
Marie Evangelista
Show All
Source
Cite
Save
Citations (177)
1